These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2072455)

  • 41. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice.
    Welsh CJ; Tonks P; Nash AA; Blakemore WF
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1659-67. PubMed ID: 2953860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection.
    Yamada M; Zurbriggen A; Fujinami RS
    Am J Pathol; 1990 Dec; 137(6):1467-79. PubMed ID: 2260633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection.
    Lipton HL; Kratochvil J; Sethi P; Dal Canto MC
    Neurology; 1984 Aug; 34(8):1117-9. PubMed ID: 6087205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus.
    Lipton HL; Dal Canto MC
    Infect Immun; 1979 Oct; 26(1):369-74. PubMed ID: 500211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.
    Nitayaphan S; Toth MM; Roos RP
    J Virol; 1985 Feb; 53(2):651-7. PubMed ID: 2578578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus.
    Aubert C; Brahic M
    J Virol; 1995 May; 69(5):3197-200. PubMed ID: 7707550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons.
    Jarousse N; Syan S; Martinat C; Brahic M
    J Virol; 1998 Sep; 72(9):7213-20. PubMed ID: 9696815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system.
    Rozhon EJ; Kratochvil JD; Lipton HL
    Virology; 1983 Jul; 128(1):16-32. PubMed ID: 6192587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis of Theiler's murine encephalomyelitis virus.
    Yamada M; Zurbriggen A; Fujinami RS
    Adv Virus Res; 1991; 39():291-320. PubMed ID: 2038955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection.
    Zurbriggen A; Thomas C; Yamada M; Roos RP; Fujinami RS
    J Virol; 1991 Apr; 65(4):1929-37. PubMed ID: 1705992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.
    Rodriguez M; Oleszak E; Leibowitz J
    Crit Rev Immunol; 1987; 7(4):325-65. PubMed ID: 2827957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uncoupled relationship between demyelination and primary infection of myelinating cells in Theiler's virus encephalomyelitis.
    Dal Canto MC
    Infect Immun; 1982 Mar; 35(3):1133-8. PubMed ID: 6279514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination.
    Wada Y; McCright IJ; Whitby FG; Tsunoda I; Fujinami RS
    J Virol; 1998 Sep; 72(9):7557-62. PubMed ID: 9696853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and characterization of two plaque size variants of Theiler's murine encephalomyelitis virus (DA strain).
    Oleszak EL; Leibowitz JL; Rodriguez M
    J Gen Virol; 1988 Sep; 69 ( Pt 9)():2413-8. PubMed ID: 2842440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis.
    Reddi HV; Kumar AS; Kung AY; Kallio PD; Schlitt BP; Lipton HL
    J Virol; 2004 Aug; 78(16):8909-16. PubMed ID: 15280499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis.
    Jelachich ML; Lipton HL
    J Virol; 1996 Oct; 70(10):6856-61. PubMed ID: 8794327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of Theiler's virus isolates from persistently infected mouse nervous tissue.
    Roos RP; Richards OC; Ehrenfeld E
    J Gen Virol; 1983 Mar; 64 Pt 3():701-6. PubMed ID: 6298351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus.
    Tsunoda I; Kurtz CI; Fujinami RS
    Virology; 1997 Feb; 228(2):388-93. PubMed ID: 9123847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses.
    Adami C; Pritchard AE; Knauf T; Luo M; Lipton HL
    J Virol; 1998 Feb; 72(2):1662-5. PubMed ID: 9445074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization.
    Stroop WG; Baringer JR; Brahic M
    Lab Invest; 1981 Dec; 45(6):504-9. PubMed ID: 7321523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.